Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices steady as investors weigh US-Iran war escalation
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
Charles River Laboratories (CRL) Tops Q4 EPS by 6c
February 16, 2022 7:05 AM ESTCharles River Laboratories (NYSE: CRL) reported Q4 EPS of $2.49, $0.06 better than the analyst estimate of $2.43. Revenue for the quarter came in at $905.1 million versus the consensus estimate of $888.31 million.
Reaffirms 2022... More
